Nantahala Capital Management’s Cellectar Biosciences CLRB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-90,415	Closed	-$5.8M	–	123
2024 Q3	$5.8M	Buy	90,415 +29,304	+48%	+$1.88M	0.29%	54
2024 Q2	$4.58M	Sell	61,111 -1,333	-2%	-$100K	0.27%	56
2024 Q1	$7.46M	Buy	62,444 +17,425	+39%	+$2.08M	0.43%	40
2023 Q4	$3.74M	Buy	+45,019	New	+$3.74M	0.22%	64